Chemistry CPRR

Notice ID:

FA301022R0006

Department/Ind. Agency:

DEPT OF DEFENSE

Sub-tier:

DEPT OF DEFENSE

Sub Command:

FA3010 81 CONS CC

Office:

FA3010 81 CONS CC

All Dates/Times are:

(utc-06:00) central standard time, chicago, usa

Updated Published Date:

jan 14, 2022 10:52 am cst

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

jan 20, 2021 02:03 pm cst

Inactive Policy:

15 days after date offers due

Updated Inactive Date:

feb 12, 2022

Original Inactive Date:

feb 04, 2021

Initiative:

• None***--***

Product Service Code:

6550 - in vitro diagnostic substances, reagents, test kits and sets

NAICS Code:

325413 - in-vitro diagnostic substance manufacturing

Original Set Aside:

Chemistry analyzers, special chemistry analyzers and automated specimen track system including use of all equipment, services, supplies and reagents needed to perform automated specimen processing that will consolidate and integrate approximately 550000 reportable patient tests per base contract year in chemistry, immunology, Hemoglobin A1C and immunoassay special chemistry. All analyzers, automated specimen track system and bidirectional contractor supplied computer interface must have ability to connect to Composite Health Care System and Cerner Genesis Lab Information System. Training will be provided with purchase. Tests billed by monthly invoice and payments will be provided in 12 installments per year. Cost-Per-Reportable-Result pricing is billed per patient result calculated from Keesler Air Force Base Medical Center Laboratory Information system and submitted to contractor the beginning of the following month. Analyzers must be in place and ready to use on or before 30 April 2022. No actual patient testing will be performed prior to 1 May 2022. Please include price breakdown and any applicable fees. Performance period is 1 May 2022-30 April 2027.

CP 228 377 3230 310 M ST BLDG 4605

KEESLER AFB , MS 39534-2701

USA

Primary Point of Contacts:

Samantha I. Conger

Secondary Point of Contact:

Kimberley L. Alvarez